Literature DB >> 16340934

Pathogenesis of anemia in cardiorenal disease.

Inder S Anand1.   

Abstract

The link between chronic heart failure (CHF) and chronic kidney disease (CKD) is well known. Approximately 50% of patients with CHF have some renal dysfunction, and 25% of patients with CKD and serum creatinine levels ranging from 1.5 mg/dL to 6 mg/dL have CHF. The association of CHF with CKD is strong and may contribute to its long-term progression. Anemia is also common in patients with CKD and contributes to increased morbidity and mortality. More recently, anemia has been found to be frequently present in patients with CHF, and its presence is associated with worse long-term CHF outcomes. Thus, anemia, CHF, and CKD may be independently related to one another, and this relationship may have important implications for their management.

Entities:  

Mesh:

Year:  2005        PMID: 16340934

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  6 in total

1.  Introduction: anemia in heart failure.

Authors:  Inder Anand
Journal:  Heart Fail Rev       Date:  2008-03-29       Impact factor: 4.214

Review 2.  Cardiorenal syndrome: a cardiologist's perspective of pathophysiology.

Authors:  Inder S Anand
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-25       Impact factor: 8.237

3.  Management of anemia and iron deficiency in heart failure.

Authors:  Eileen O'Meara; Simon de Denus
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-12

Review 4.  Heart failure and anemia: mechanisms and pathophysiology.

Authors:  Inder S Anand
Journal:  Heart Fail Rev       Date:  2008-01-31       Impact factor: 4.214

Review 5.  The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes.

Authors:  Yi-Da Tang; Stuart D Katz
Journal:  Heart Fail Rev       Date:  2008-02-02       Impact factor: 4.214

Review 6.  Animal models of cardiorenal syndrome: a review.

Authors:  Mariusz K Szymanski; Rudolf A de Boer; Gerjan J Navis; Wiek H van Gilst; Hans L Hillege
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.